• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Will We Ever Decide What Antithrombotic Regimen to Use After Stenting?

作者信息

King Spencer B

机构信息

5665 Peachtree Dunwoody Road NE, Atlanta, GA 30342.

出版信息

Cardiovasc Revasc Med. 2020 May;21(5):702-703. doi: 10.1016/j.carrev.2020.05.026.

DOI:10.1016/j.carrev.2020.05.026
PMID:32600799
Abstract
摘要

相似文献

1
Will We Ever Decide What Antithrombotic Regimen to Use After Stenting?我们究竟何时才能确定支架置入术后使用何种抗血栓治疗方案？
Cardiovasc Revasc Med. 2020 May;21(5):702-703. doi: 10.1016/j.carrev.2020.05.026.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.从治疗方案的选择到治疗强度的选择：接受经皮冠状动脉介入治疗的房颤患者抗栓治疗观念的转变
Cardiovasc Drugs Ther. 2020 Feb;34(1):143-144. doi: 10.1007/s10557-019-06903-y.
4
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.多学科方法在冠状动脉支架置入术后手术患者围手术期抗栓治疗中的应用：支架术后手术 2 。
JACC Cardiovasc Interv. 2018 Mar 12;11(5):417-434. doi: 10.1016/j.jcin.2017.10.051.
5
Dual therapy with direct oral anticoagulants significantly increases the risk of stent thrombosis compared to triple therapy.与三联疗法相比，直接口服抗凝剂的双联疗法显著增加了支架血栓形成的风险。
Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):128-129. doi: 10.1093/ehjcvp/pvz030.
6
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.双联或三联抗栓治疗患者的出血和缺血结局：系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):226-236. doi: 10.1093/ehjcvp/pvz021.
7
Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.急性冠状动脉综合征或经皮冠状动脉介入治疗后房颤患者的双联与三联抗栓治疗：一项更新的荟萃分析
Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20.
8
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.心房颤动和冠心病患者经皮冠状动脉介入治疗中的抗血栓治疗。
J Cardiovasc Pharmacol. 2019 Aug;74(2):82-90. doi: 10.1097/FJC.0000000000000697.
9
Antithrombotic Treatment Regimens in Patients Undergoing Percutaneous Coronary Revascularization Requiring Oral Anticoagulation: What Real-World Evidence Shows Us.接受经皮冠状动脉血运重建且需要口服抗凝治疗的患者的抗栓治疗方案：真实世界证据向我们展示了什么。
J Cardiovasc Pharmacol. 2024 Oct 1;84(4):391-393. doi: 10.1097/FJC.0000000000001619.
10
Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta-analysis.抗凝治疗患者行经皮冠状动脉介入治疗中单联与双联抗血小板治疗的疗效和安全性：系统评价和荟萃分析。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2460-2472. doi: 10.1111/jce.14132. Epub 2019 Aug 29.